The National Cancer Institute aims to lessen the burden of cancer through scientific evidence. In 2016, there will be an estimated 1.7 million new cancer cases and 600,000 cancer deaths in the United States. Precision medicine will lead to a fundamental understanding of the complex interplay between genetics, epigenetics, nutrition, environment and clinical presentation to direct effective cancer prevention and treatment. The Cancer Moonshot initiative utilizes precision medicine, national computing initiatives, and making genomic data widely available to investigate and explore cancer prediction using real-world data.